Gastric Preparation of Magnetic-controlled Capsule Endoscopy

NCT02846155 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-07-27

No results posted yet for this study

Summary

By using three different Gastric Preparation of Magnetic-controlled Capsule Endoscopy, the investigators hope to find out the optimal gastric preparation plan.

Conditions

  • Stomach Diseases

Interventions

OTHER

clear water

the patients just drink common clear water before Magnetic-controlled Capsule Endoscopy examination

DRUG

simethicone

the patients drink clear water and simethicone (Espumisan; Berlin-Chemie, Germany, containing 40 mg simethicone in 1 mL emulsion) before Magnetic-controlled Capsule Endoscopy examination

DRUG

simethicone combined with pronase

the patients drink simethicone (Espumisan; Berlin-Chemie, Germany, containing 40 mg simethicone in 1 mL emulsion),pronase granules(Deyou;Beijing Tide Pharmaceutical Co,China,containing 20,000iu pronase),and clear water before Magnetic-controlled Capsule Endoscopy examination

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02846155 on ClinicalTrials.gov